Delivery Order SPE2DR25D3004-SPE2DR26FXVM7
Award Date 1/27/26
Potential Completion Date 2/18/26
Potential Value $75K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a $6,928.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 110 mg Artesunate vials, with an ultimate completion date of May 23, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was issued to the contractor's Corporate Office...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $34,045.40 by the Defense Logistics Agency on January 23, 2026, for the supply of Artesunate 110 mg vials. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is February 13, 2026, and the place of performance is located at the awardee's corporate...
- The Defense Logistics Agency (DLA) awarded a $20,786.31 delivery order to AmerisourceBergen Drug Corp for the supply of Artesunate 110 mg vials, with a completion date of September 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The contract includes no set-aside designation,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,928.76 to AmerisourceBergen Drug Corp for the supply of Artesunate 110 mg vials. This competitive delivery order, issued on May 27, 2025, with completion expected by May 28, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for...
- This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, has a potential value of one hundred five thousand six hundred eighty-five dollars and seventy-six cents ($105,685.76) to supply four hundred fifty-six thousand two hundred forty-eight thousand nine hundred ninety-four (4562489499) units of artesunate, a medication used to treat malaria, in one hundred ten (110) milligram vials. The contract has a firm fixed price and period of performance through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ARTESUNAT 110MG 2S pharmaceutical products. The $19,920.75 contract has a performance period through March 6, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, most notably the Department...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,069.37, is for the delivery of the pharmaceutical product Artesunat 110mg 2s. This is a firm-fixed-price delivery order contract with a completion date of May 16, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,238.07 delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for Coartem Tablets 24S, an antimalarial medication commonly used for treatment of malaria in military and defense health applications. This non-competitive, firm fixed-price delivery order, which is due for completion by April 24, 2025, represents a discrete purchase against AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,562.33 to AmerisourceBergen Drug Corp for Coartem Tablets 24S, a pharmaceutical product used in malaria treatment. The contract is non-competitive and employs firm fixed-price pricing, with a completion date of January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $5,762.64 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a combination antimalarial medication. The award, issued on January 16, 2026, is a firm fixed-price delivery order with an ultimate completion date of January 20, 2026. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...